CRIS Competitors & Alternatives
Compare Curis Inc with similar stocks in the same industry
Biotechnology
CRIS
Main Stock$1.58
Tradestie Score
50
Market Cap
$20.87M
P/E Ratio
0.4
Revenue Growth
-0.7%
Analyst Upside
+2600.4%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$23.87
|
$154.27M | - | 40 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$16.40
|
$133.50M | - | 33 | Compare |
|
AGEN
Agenus Inc.
|
$7.67
|
$124.27M | 2.7 | 37 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.90
|
$114.01M | - | 35 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$36.25
|
$110.20M | - | 35 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.82
|
$97.42M | - | 45 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.47
|
$85.47M | - | 36 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.42
|
$84.52M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.52
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.61
|
$67.94M | - | 34 | Compare |
More CRIS Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
239 stocks in this industry